SS Innovations Appoints New CFO as Global Expansion Accelerates
SS Innovations International, a surgical robot developer, has announced the appointment of Naveen Kumar Amar as its new Chief Financial Officer. This strategic move comes as the company prepares to expand its global footprint, particularly in Europe and the United States.
Leadership Transition and Strategic Goals
Amar, who assumed his role on September 24, 2025, replaces Vishwa Srivastava, who had been serving as interim CFO since July. Srivastava will continue his involvement with the company as CEO for the Asia Pacific region.
The appointment aligns with SS Innovations' focus on expanding sales of its SSi Mantra surgical robot globally. CEO Sudhir Srivastava emphasized the significance of Amar's addition to the leadership team, stating, "We are thrilled to welcome a seasoned financial executive of his caliber to our leadership team as we expand the global presence of our advanced, cost-efficient SSi Mantra surgical robotic system."
Amar's Extensive Background
Naveen Kumar Amar brings a wealth of experience to his new position at SS Innovations. His prior roles include:
- Head of finance and commercial for SpiceXpress
- Global CFO for software provider Munch Ado India
- Senior vice president of finance and compliance for vaccine manufacturer MSD Wellcome Trust Hilleman Laboratories
- CFO for India and Australia at telecommunications company EDirect Proprietary
- India manager of financial consolidation for GE India
Most recently, Amar provided virtual CFO services to clients in the United States, Canada, and the United Kingdom, further broadening his international financial expertise.
SSi Mantra's Market Position and Regulatory Progress
SS Innovations has positioned its SSi Mantra robot as a more affordable alternative to Intuitive Surgical's da Vinci system, potentially disrupting the surgical robotics market. The device has already gained approval in seven countries, including India, Indonesia, and the Philippines.
The company is now setting its sights on major markets in the West. SS Innovations expects to receive Europe's CE mark during the first half of 2026, marking a significant milestone in its expansion plans. In the United States, the company aims to submit a 510(k) application to the Food and Drug Administration by the end of October 2025, paving the way for potential market entry in North America.
References
- SS Innovations hires new CFO
Naveen Kumar Amar joins the surgical robot developer as it prepares to expand globally, including in Europe and the U.S.
Explore Further
What specific financial strategies or initiatives will Naveen Kumar Amar prioritize to support SS Innovations' global expansion?
How does SS Innovations plan to navigate regulatory approval processes in key markets like Europe and the United States?
What are the primary challenges SS Innovations anticipates in competing with established surgical robotic systems like Intuitive Surgical's da Vinci?
What has been the historical impact of leadership changes at SS Innovations on its financial performance and market growth?
Are there recent similar personnel changes in other companies within the surgical robotics industry, and how do they compare to SS Innovations' approach?